{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:42:45Z","timestamp":1793241765979,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018998","name":"Ege University Research Foundation","doi-asserted-by":"publisher","award":["PROJE_ID_21886"],"award-info":[{"award-number":["PROJE_ID_21886"]}],"id":[{"id":"10.13039\/501100018998","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30686-y","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:24:48Z","timestamp":1769221488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6856-4644","authenticated-orcid":false,"given":"Neslihan Pinar","family":"Ozates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-7455","authenticated-orcid":false,"given":"Bakiye Goker","family":"Bagca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-4175","authenticated-orcid":false,"given":"Aycan","family":"Asik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-3237","authenticated-orcid":false,"given":"Cumhur","family":"Gunduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-5555","authenticated-orcid":false,"given":"Haluk","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-4520","authenticated-orcid":false,"given":"Cigir Biray","family":"Avci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"30686_CR1","doi-asserted-by":"publisher","unstructured":"Goker Bagca, B., Ozates, N. P. & Biray Avci, C. Ruxolitinib enhances cytotoxic and apoptotic effects of Temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes. Med. Oncol. 40 (1),\u00a0https:\/\/doi.org\/10.1007\/S12032-022-01897-4 (2022).","DOI":"10.1007\/S12032-022-01897-4"},{"issue":"1","key":"30686_CR2","doi-asserted-by":"publisher","first-page":"8013575","DOI":"10.1155\/2017\/8013575","volume":"2017","author":"W Szopa","year":"2017","unstructured":"Szopa, W., Burley, T. A., Kramer-Marek, G. & Kaspera, W. Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives. Biomed. Res. Int. 2017 (1), 8013575. https:\/\/doi.org\/10.1155\/2017\/8013575 (2017).","journal-title":"Biomed. Res. Int."},{"key":"30686_CR3","doi-asserted-by":"publisher","unstructured":"Masliantsev, K., Karayan-tapon, L. & Guichet, P. O. \u2018Hippo signaling pathway in gliomas\u2019, 01, MDPI. (2021). https:\/\/doi.org\/10.3390\/cells10010184","DOI":"10.3390\/cells10010184"},{"key":"30686_CR4","doi-asserted-by":"publisher","unstructured":"Piccolo, S., Dupont, S. & Cordenonsi, M. The biology of YAP\/TAZ: Hippo signaling and beyond. Physiol. Rev. 94 (4), 1287\u20131312. https:\/\/doi.org\/10.1152\/physrev.00005.2014 (2014).","DOI":"10.1152\/physrev.00005.2014"},{"key":"30686_CR5","doi-asserted-by":"publisher","unstructured":"Kulkarni, A., Chang, M. T., Vissers, J. H. A., Dey, A. & Harvey, K. F. \u2018The Hippo Pathway as a Driver of Select Human Cancers\u2019, 01, 2020, Cell Press. https:\/\/doi.org\/10.1016\/j.trecan.2020.04.004","DOI":"10.1016\/j.trecan.2020.04.004"},{"issue":"7","key":"30686_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1158\/1541-7786.MCR-12-0116","volume":"10","author":"GS Baia","year":"2012","unstructured":"Baia, G. S. et al. Yes-associated protein 1 is activated and functions as an oncogene in meningiomas. Mol. Cancer Res. 10 (7), 904\u2013913. https:\/\/doi.org\/10.1158\/1541-7786.MCR-12-0116 (2012).","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"30686_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/NEN.0B013E31821FF8D8","volume":"70","author":"BA Orr","year":"2011","unstructured":"Orr, B. A. et al. Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth. J. Neuropathol. Exp. Neurol. 70 (7), 568\u2013577. https:\/\/doi.org\/10.1097\/NEN.0B013E31821FF8D8 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"30686_CR8","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-20-0018","volume":"27","author":"K Vigneswaran","year":"2021","unstructured":"Vigneswaran, K. et al. YAP\/TAZ transcriptional coactivators create therapeutic vulnerability to verteporfin in EGFR-mutant glioblastoma. Clin. Cancer Res. 27 (5), 1553\u20131569. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-0018 (2021).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"30686_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/JCB.27393","volume":"120","author":"F Sogutlu","year":"2019","unstructured":"Sogutlu, F. et al. The effect of ICRT-3 on Wnt signaling pathway in head and neck cancer. J. Cell. Biochem. 120 (1), 380\u2013395. https:\/\/doi.org\/10.1002\/JCB.27393 (2019).","journal-title":"J. Cell. Biochem."},{"key":"30686_CR10","doi-asserted-by":"publisher","first-page":"145001","DOI":"10.1016\/J.GENE.2020.145001","volume":"759","author":"A Kusoglu","year":"2020","unstructured":"Kusoglu, A., Goker Bagca, B., Ozates Ay, N. P. & Gunduz, C. Biray Avci, \u2018Telomerase Inhibition regulates EMT mechanism in breast cancer stem cells\u2019. Gene 759, 145001. https:\/\/doi.org\/10.1016\/J.GENE.2020.145001 (2020).","journal-title":"Gene"},{"key":"30686_CR11","unstructured":"\u2018Gene Regulation Analysis & Interpretation | QIAGEN\u2019. Accessed: Aug. 25, 2025. [Online]. Available: https:\/\/digitalinsights.qiagen.com\/research-and-discovery\/gene-regulation\/?gad_source=1&gad_campaignid=21528165982&gbraid=0AAAAADbyWl2md924jjk9JlSCQfQK9MNqz&gclid=CjwKCAjwk7DFBhBAEiwAeYbJsU5Zu_aUK0YfaPf_Y_Q3bagqHgVlytOUdgZvGTvIvkyuE1PWlGOdshoC3nAQAvD_BwE."},{"key":"30686_CR12","unstructured":"\u2018DAVID Functional Annotation Bioinformatics Microarray Analysis\u2019. Accessed: Aug. 25, 2025. [Online]. Available: https:\/\/davidbioinformatics.nih.gov\/"},{"issue":"1","key":"30686_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/S12672-025-02567-3","volume":"16","author":"J Pu","year":"2025","unstructured":"Pu, J. et al. Glioblastoma multiforme: an updated overview of Temozolomide resistance mechanisms and strategies to overcome resistance. Discover Oncol. 16 (1), 731. https:\/\/doi.org\/10.1007\/S12672-025-02567-3 (2025).","journal-title":"Discover Oncol."},{"key":"30686_CR14","doi-asserted-by":"publisher","unstructured":"DeCordova, S. et al. Molecular heterogeneity and immunosuppressive microenvironment in glioblastoma. Front. Immunol. 11 https:\/\/doi.org\/10.3389\/FIMMU.2020.01402 (2020).","DOI":"10.3389\/FIMMU.2020.01402"},{"key":"30686_CR15","doi-asserted-by":"publisher","unstructured":"Uwishema, O. et al. Stem cell therapies and glioma stem cells in glioblastoma: a systematic review of current challenges and research directions. Int. J. Emerg. Med. 18 (1), https:\/\/doi.org\/10.1186\/S12245-025-00921-4 (2025).","DOI":"10.1186\/S12245-025-00921-4"},{"issue":"4","key":"30686_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/ONCO4040024","volume":"4","author":"N Baxevanis","year":"2024","unstructured":"Baxevanis, N., Pawelec, G. P., Malhotra, P. & Rahman, R. Tumour heterogeneity and disease infiltration as paradigms of glioblastoma treatment resistance. Onco 4 (4), 349\u2013358. https:\/\/doi.org\/10.3390\/ONCO4040024 (2024).","journal-title":"Onco"},{"issue":"1","key":"30686_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/NAR\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330. https:\/\/doi.org\/10.1093\/NAR\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"30686_CR18","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/PRO.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951. https:\/\/doi.org\/10.1002\/PRO.3715 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"30686_CR19","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/NAR\/GKAC963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D592. https:\/\/doi.org\/10.1093\/NAR\/GKAC963 (2023).","journal-title":"Nucleic Acids Res."},{"key":"30686_CR20","doi-asserted-by":"publisher","unstructured":"Mukhtar, M. et al. \u2018Nanomaterials for Diagnosis and Treatment of Brain Cancer: Recent Updates\u2019, Chemosensors 8, Page 8 (4), 117 (2020). https:\/\/doi.org\/10.3390\/CHEMOSENSORS8040117","DOI":"10.3390\/CHEMOSENSORS8040117"},{"issue":"23","key":"30686_CR21","doi-asserted-by":"publisher","first-page":"9065","DOI":"10.1158\/0008-5472.CAN-09-2307","volume":"69","author":"LAM Gravendeel","year":"2009","unstructured":"Gravendeel, L. A. M. et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res. 69 (23), 9065\u20139072. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2307 (2009).","journal-title":"Cancer Res."},{"key":"30686_CR22","doi-asserted-by":"publisher","unstructured":"Fernandez-L, A. et al. \u2018Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation\u2019, Oncogene, 31 (15), 1923\u20131937, (2012). https:\/\/doi.org\/10.1038\/ONC.2011.379","DOI":"10.1038\/ONC.2011.379"},{"issue":"8","key":"30686_CR23","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3390\/CELLS9081761","volume":"9","author":"EH Kim","year":"2020","unstructured":"Kim, E. H. et al. Silence of Hippo pathway associates with Pro-Tumoral immunosuppression: potential therapeutic target of glioblastomas. Cells 2020. 9 (8), 1761. https:\/\/doi.org\/10.3390\/CELLS9081761 (2020).","journal-title":"Cells 2020"},{"key":"30686_CR24","doi-asserted-by":"crossref","unstructured":"Miao, N. et al. \u2018Overexpression of ZEB1 and YAP1 is related to poor prognosis in patients with gliomas with different IDH1 status\u2019, Int J Clin Exp Pathol, 16 (7), 138, 2023, Accessed: Nov. 21, 2023. [Online]. Available: \/pmc\/articles\/PMC10408435\/","DOI":"10.62347\/EZUU6668"},{"issue":"2","key":"30686_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/S11060-021-03699-6","volume":"152","author":"JT Saunders","year":"2021","unstructured":"Saunders, J. T. et al. Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma. J. Neurooncol. 152 (2), 217\u2013231. https:\/\/doi.org\/10.1007\/S11060-021-03699-6 (2021).","journal-title":"J. Neurooncol"},{"key":"30686_CR26","doi-asserted-by":"publisher","unstructured":"Masliantsev, K., Karayan-tapon, L. & Guichet, P. O. \u2018Hippo Signaling Pathway in Gliomas\u2019, Cells 10, Page 10 (1), 184 (2021). https:\/\/doi.org\/10.3390\/CELLS10010184","DOI":"10.3390\/CELLS10010184"},{"key":"30686_CR27","doi-asserted-by":"publisher","unstructured":"Dixon, S. J. et al. \u2018Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell Death\u2019, 2015, https:\/\/doi.org\/10.1021\/acschembio.5b00245","DOI":"10.1021\/acschembio.5b00245"},{"issue":"7","key":"30686_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/NCHEMBIO.2079","volume":"12","author":"K Shimada","year":"2016","unstructured":"Shimada, K. et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat. Chem. Biol. 12 (7), 497. https:\/\/doi.org\/10.1038\/NCHEMBIO.2079 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"30686_CR29","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.chembiol.2019.09.014","volume":"26","author":"J Ko","year":"2019","unstructured":"Ko, J. et al. A ZDHHC5-GOLGA7 protein acyltransferase complex promotes nonapoptotic cell death. Cell. Chem. Biol. 26, 1716\u20131724e9. https:\/\/doi.org\/10.1016\/j.chembiol.2019.09.014 (2019).","journal-title":"Cell. Chem. Biol."},{"key":"30686_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/J.BIOMATERIALS.2019.04.020","volume":"209","author":"KL Kozielski","year":"2019","unstructured":"Kozielski, K. L. et al. Cancer-selective nanoparticles for combinatorial SiRNA delivery to primary human GBM in vitro and in vivo. Biomaterials 209, 79\u201387. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2019.04.020 (2019).","journal-title":"Biomaterials"},{"issue":"1","key":"30686_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/IJMS17010138","volume":"17","author":"Y Zhou","year":"2016","unstructured":"Zhou, Y. et al. The TEAD family and its oncogenic role in promoting tumorigenesis. Int. J. Mol. Sci. 17 (1), 138. https:\/\/doi.org\/10.3390\/IJMS17010138 (2016).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"30686_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/J.GENDIS.2020.05.004","volume":"8","author":"T Sun","year":"2021","unstructured":"Sun, T. & Chi, J. T. Regulation of ferroptosis in cancer cells by YAP\/TAZ and Hippo pathways: the therapeutic implications. Genes Dis. 8 (3), 241\u2013249. https:\/\/doi.org\/10.1016\/J.GENDIS.2020.05.004 (2021).","journal-title":"Genes Dis."},{"key":"30686_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/J.FREERADBIOMED.2018.05.074","volume":"133","author":"R Kang","year":"2019","unstructured":"Kang, R., Kroemer, G. & Tang, D. The tumor suppressor protein p53 and the ferroptosis network. Free Radic Biol. Med. 133, 162\u2013168. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2018.05.074 (2019).","journal-title":"Free Radic Biol. Med."},{"issue":"1","key":"30686_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/CDD.2017.171","volume":"25","author":"AM Kaiser","year":"2018","unstructured":"Kaiser, A. M. & Attardi, L. D. Deconstructing networks of p53-mediated tumor suppression in vivo. Cell. Death Differ. 25 (1), 93. https:\/\/doi.org\/10.1038\/CDD.2017.171 (2018).","journal-title":"Cell. Death Differ."},{"key":"30686_CR35","doi-asserted-by":"publisher","unstructured":"Mou, Y. et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J. Hematol. Oncol. 12 (1), https:\/\/doi.org\/10.1186\/S13045-019-0720-Y (2019).","DOI":"10.1186\/S13045-019-0720-Y"},{"key":"30686_CR36","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. \u2018YAP Promotes Migration and Invasion of Human Glioma Cells\u2019, (2018). https:\/\/doi.org\/10.1007\/s12031-017-1018-6","DOI":"10.1007\/s12031-017-1018-6"},{"key":"30686_CR37","doi-asserted-by":"crossref","unstructured":"Lee, C. K. et al. \u2018Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation Downloaded from\u2019, 2019. [Online]. Available: http:\/\/science.sciencemag.org\/","DOI":"10.1126\/science.aav0173"},{"issue":"3","key":"30686_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7150\/JCA.38350","volume":"11","author":"W Fu","year":"2020","unstructured":"Fu, W. et al. Bazedoxifene enhances Paclitaxel efficacy to suppress glioblastoma via altering Hippo\/YAP pathway. J. Cancer. 11 (3), 657\u2013667. https:\/\/doi.org\/10.7150\/JCA.38350 (2020).","journal-title":"J. Cancer"},{"issue":"1","key":"30686_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S41016-020-00207-Z\/METRICS","volume":"6","author":"R Guan","year":"2020","unstructured":"Guan, R., Zhang, X. & Guo, M. Glioblastoma stem cells and Wnt signaling pathway: molecular mechanisms and therapeutic targets. Chin. Neurosurg. J. 6 (1), 1\u20136. https:\/\/doi.org\/10.1186\/S41016-020-00207-Z\/METRICS (2020).","journal-title":"Chin. Neurosurg. J."},{"issue":"2","key":"30686_CR40","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/S12035-018-1150-5\/FIGURES\/6","volume":"56","author":"D Matias","year":"2019","unstructured":"Matias, D. et al. GBM-Derived Wnt3a induces M2-Like phenotype in microglial cells through Wnt\/\u03b2-Catenin signaling. Mol. Neurobiol. 56 (2), 1517\u20131530. https:\/\/doi.org\/10.1007\/S12035-018-1150-5\/FIGURES\/6 (2019).","journal-title":"Mol. Neurobiol."},{"key":"30686_CR41","unstructured":"Gloscow, E. J. New Research on Genomic Instability (Nova Biomedical Books, 2007)."},{"key":"30686_CR42","doi-asserted-by":"publisher","unstructured":"Okura, H. et al. \u2018A role for activated Cdc42 in glioblastoma multiforme invasion\u2019, Oncotarget, 7 (35), 56958, (2016). https:\/\/doi.org\/10.18632\/ONCOTARGET.10925","DOI":"10.18632\/ONCOTARGET.10925"},{"issue":"1","key":"30686_CR43","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/J.YEXCR.2016.11.024","volume":"350","author":"HH Ling","year":"2017","unstructured":"Ling, H. H., Kuo, C. C., Lin, B. X., Huang, Y. H. & Lin, C. W. Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer. Exp. Cell. Res. 350 (1), 218\u2013225. https:\/\/doi.org\/10.1016\/J.YEXCR.2016.11.024 (2017).","journal-title":"Exp. Cell. Res."},{"key":"30686_CR44","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.2147\/OTT.S247699","volume":"13","author":"Z Huang","year":"2020","unstructured":"Huang, Z. et al. YAP1 promotes tumor invasion and metastasis in nasopharyngeal carcinoma with hepatitis B virus infection. Onco Targets Ther. 13, 5629\u20135642. https:\/\/doi.org\/10.2147\/OTT.S247699 (2020).","journal-title":"Onco Targets Ther."},{"key":"30686_CR45","doi-asserted-by":"publisher","unstructured":"Xu, W., Gong, F., Zhang, T., Chi, B. & Wang, J. RNA-binding protein Dnd1 inhibits epithelial\u2013mesenchymal transition and cancer stem cell-related traits on hepatocellular carcinoma cells. Biotechnol. Lett. 39 (9), 1359\u20131367. https:\/\/doi.org\/10.1007\/S10529-017-2375-5\/FIGURES\/5 (2017).","DOI":"10.1007\/S10529-017-2375-5\/FIGURES\/5"},{"key":"30686_CR46","doi-asserted-by":"publisher","unstructured":"Lehmann, W. et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat. Commun. 7 https:\/\/doi.org\/10.1038\/NCOMMS10498 (2016).","DOI":"10.1038\/NCOMMS10498"},{"key":"30686_CR47","doi-asserted-by":"publisher","unstructured":"Ishiguro, T. et al. \u2018Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications\u2019, Cancer Sci, 108 (3), 283 (2017). https:\/\/doi.org\/10.1111\/CAS.13155","DOI":"10.1111\/CAS.13155"},{"key":"30686_CR48","doi-asserted-by":"publisher","unstructured":"Liu, Z. et al. \u2018Differential YAP Expression Glioma Cells Induces cell. Competition Promotes Tumorigenesis\u2019, J. Cell Science Vol. 132,5 jcs225714. 4 Mar. https:\/\/doi.org\/10.1242\/jcs.225714 (2019).","DOI":"10.1242\/jcs.225714"},{"issue":"3","key":"30686_CR49","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/CANCERS11030406","volume":"11","author":"A Kowalski-Chauvel","year":"2019","unstructured":"Kowalski-Chauvel, A. et al. Alpha6-Integrin regulates FGFR1 expression through the ZEB1\/YAP1 transcription complex in glioblastoma stem cells resulting in enhanced proliferation and stemness. Cancers (Basel). 11 (3), 406. https:\/\/doi.org\/10.3390\/CANCERS11030406 (2019).","journal-title":"Cancers (Basel)"}],"updated-by":[{"DOI":"10.1038\/s41598-026-48298-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30686-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30686-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30686-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:59:19Z","timestamp":1776776359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30686-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30686"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30686-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-48298-5","URL":"https:\/\/doi.org\/10.1038\/s41598-026-48298-5","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3679"}}